Pharmaceutical formulations for dry powder inhalers

Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S045000, C424S489000, C424S490000, C424S493000

Reexamination Certificate

active

07541022

ABSTRACT:
A powder for use in a dry powder inhaler comprises: i) a fraction n of fine particle size constituted by a mixture of physiologically acceptable excipient and an additive; ii) a fraction of coarse particles; and iii) at least one active ingredient. The powder is suitable for efficacious delivery of active ingredients into the low respiratory tract of patients suffering from pulmonary diseases such as asthma. In particular, the invention provides a formulation to be administered as dry powder for inhalation which is freely flowable, can be produced in a simple way, is physically and chemically stable and capable of delivering accurate doses and/or high fine particle fraction of low strength active ingredients by using a high- or medium resistance device.

REFERENCES:
patent: 1242211 (1917-10-01), Raymond et al.
patent: 6153224 (2000-11-01), Staniforth
patent: 6475523 (2002-11-01), Staniforth
patent: 6521260 (2003-02-01), Staniforth
patent: 6528096 (2003-03-01), Musa et al.
patent: 6641844 (2003-11-01), Musa et al.
patent: 6884794 (2005-04-01), Staniforth et al.
patent: 2003/0162835 (2003-08-01), Staniforth et al.
patent: 2003/0165436 (2003-09-01), Staniforth et al.
patent: 2003/0175214 (2003-09-01), Staniforth et al.
patent: 2003/0180227 (2003-09-01), Staniforth et al.
patent: 2004/0037785 (2004-02-01), Staniforth et al.
patent: 2004/0047810 (2004-03-01), Staniforth et al.
patent: 2004/0071635 (2004-04-01), Staniforth et al.
patent: 2005/0152849 (2005-07-01), Staniforth
patent: 2006/0147389 (2006-07-01), Staniforth et al.
patent: 0441740 (1991-01-01), None
patent: 0663815 (1992-12-01), None
patent: 1242211 (1967-08-01), None
patent: 1381872 (1971-06-01), None
patent: 1571629 (1997-11-01), None
patent: WO 8705213 (1987-02-01), None
patent: WO 9511666 (1995-05-01), None
patent: WO 9623485 (1996-01-01), None
patent: WO 9602231 (1996-02-01), None
patent: WO 9703649 (1997-02-01), None
patent: WO 9831351 (1998-01-01), None
patent: WO 0028979 (2000-03-01), None
patent: WO 00/33789 (2000-06-01), None
patent: WO 0033789 (2000-06-01), None
patent: WO 0053157 (2000-09-01), None
patent: WO 01/78693 (2001-10-01), None
Cassie, A..B.D., et al., Wettability of Porous Surfaces, Jun. 19, 1944, pp. 546-551.
Hancock, Bruno C., et al., Characteristics and Significance of the Amorphous State in Pharmaceutical Systems, Journal of Pharm Sci., vol. 86, No. 1, pp. 1-12, Jan. 1997.
Meggle Spherloc 100 Product Description.
Excerpt from N.M. Kassem (1990) “Generation of deeply inspirable clouds from dry powder mixtures” University of London.
D. Ganderton “The Generation of Respirable Clouds Form Coarse Powder Aggregates” Journal of Biopharmaceutical Sciences 3: 1-2; 101-105 (1992).
Y. Kawashima et al. “Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate” International Journal of Pharmaceutics 172; 179-188 (1998).
F. Podczeck “The Influence of Particle Size Distribution and Surface Roughness of Carrier Particles on the in vitro Properties of Dry Powder Inhalations” Aerosol Science and Technology 31; 301-312 (1999).
Notice of Opposition to corresponding European Patent No. EP 1 276 473.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical formulations for dry powder inhalers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations for dry powder inhalers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations for dry powder inhalers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4071835

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.